64
video
How Philanthropic Capital Can Spark 21st Century Innovations
Properly invested, philanthropic capital can reap world-changing dividends.
video
Which Way for Emerging Markets in 2018?
Seen as a monolith, emerging-market economies are expected to continue to grow at over four percen
t in coming years. But within the EM ecosystem, divergent growth stories have emerged.
+ Read More
video
A Glance through the Global Trade Window: Like the View?
Much of the growth in global prosperity in recent decades has been driven by increasingly open mar
kets in trade and financial flows.
+ Read More
video
Immigration, Workforce and the New Europe
As Brexit nears, multinational corporations are reassessing their long-term investments in Britain
, with many questioning exactly how Brexit will affect trade across the European Union.
+ Read More
video
London Falling? Fact vs. Fiction
With the possible post-Brexit change in the UK's access to the single European market, what are th
e odds that London will lose its crown as the financial capital of Europe?
+ Read More
video
Expanding the European Economy: The Role of Capital Markets
Brexit has dominated European economic and political discourse for months, with no sign of letting
up.
+ Read More
video
System Thinking to Drive Patient Engagement: Walking the Talk
The first chief patient officer role was created in 2014, and since then, biopharmaceutical compan
ies have created similar positions, restructured teams, and convened internal meetings to advance patient engagement and patient-centered practices through
+ Read More
video
Confronting the Obesity and Diabetes Epidemics
An estimated 30.3 million people in the U.S. have diabetes, or 9.4% of the population. In 2017, th
e costs of diagnosed diabetes totaled $327 billion, including $237 billion in health care costs and $90 billion in reduced productivity.
+ Read More
video
Regulating Medical Innovation in the Digital Age
Over the last decade, the Food and Drug Administration has worked hard to take a more nimble appro
ach to regulation, increase the number of approvals, prioritize truly innovative products, and integrate patient perspective into its evaluations.
+ Read More
video
A Conversation with Scott Gottlieb, Commissioner, U.S. Food and Drug Administration
This closing session will begin with a conversation with Scott Gottlieb, Commissioner, U.S. Food a
nd Drug Administration, moderated by FasterCures' Tanisha Carino.
+ Read More
video
A Conversation with Dan Gilbert
Join Dan Gilbert, founder and chairman of Quicken Loans and Rock Ventures, and majority owner of t
he NBA Cleveland Cavaliers, as he discusses his philanthropic journey, from curing rare disease to revitalizing his hometown of Detroit.
+ Read More
video
Creating a Culture of Biomedical Innovation
Over the past decade, business courses, magazines, and media outlets have overflowed with advice a
nd research on how companies can "create a culture of innovation." Recommendations such as embrace failure, eliminate hierarchy, be transparent, and promot
+ Read More